ASPREVA ANNOUNCES PRELIMINARY REVENUES FOR FIRST QUARTER 2006 AND REVISES GUIDANCE

Aspreva Pharmaceuticals Corporation , an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines for patients with less common diseases, today announced preliminary revenues of approximately US$62 million for the first quarter of 2006.

MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=PR&Date=20060413&ID=5642170)